Background Threat of morbidity and mortality in individuals with severe center
Background Threat of morbidity and mortality in individuals with severe center failing (HF) is reduced by blockade of aldosterone receptors with spironolactone. an ACE inhibitor, 59.5% used a beta-blocker, 28.4% used an ARB, and 15.1% (n = 12,344) used spironolactone. Despite underestimation because of limitation from the data source, the documented occurrence of hyperkalemia (3.3% … [Read more…]